the difference between tirzepatide and semaglutide vs. Semaglutide: What You Should Know Comparative safety and side effects

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L

Case reports of KD addressing anxiety describe two cases of decreased anxiety symptoms in a woman with women, one with bipolar I disorder and another with unspecified mood disorder, comorbid emotional dysregulation, body dysmorphic disorder, and eating disorder (36, 37), and one case report that describes the elimination of anxiety symptoms in a man with bipolar disorder (38)

Insurance coverage for off-label use may be limited, creating significant financial barriers for many patients

Interestingly, the Canadian Patent Register includes none of the semaglutide patents, so parties cannot enforce them through the linkage regime